Skip to main content

Table 5 Query results for query #6

From: The Translational Medicine Ontology and Knowledge Base: driving personalized medicine by bridging the gap between bench and bedside

name patient
Benny Smith
Georg Steffen Möller
  1. AD patients in TMKB without the APOE4 allele as these would be good candidates for the clinical trial involving Bapineuzumab.